1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
21 
in a Smte in which a recombinant DXA activity is being 
conducted or in the case of individuals conducting an inspec- 
tion for a local biohazards committee, anj 7 facility under the 
jurisdiction of such committee in which a recombinant DXA 
activity is being conducted. A separate notice shall be given 
for each such inspection, but a separate notice shall not be 
required for each entry made during the period covered by 
the inspection. Such an inspection (A) shall be made during 
the normal business hours of the facility being inspected and 
in a reasonable manner, and (B) may extend to relevant 
equipment, materials, containers, records, files, papers, proc- 
esses, controls, facilities, and all other things in the facility 
bearing on whether the recombinant DXA. activity’ is being 
conducted in accordance with the licensing requirements of 
this part. 
“(2) Upon completion of any inspection of a facility 
authorized by paragraph (1) and prior to leaving the fa- 
cility, the individual making the inspection shall give to* the 
owner, operator, or agent in charge a preliminary report 
which summarizes any condition or practice observed by him 
which, in his judgment, indicates a violation of the licensing 
requirements of this part. He shall also prepare a written 
final report of his findings and send it to such owner, opera- 
tor, or agent within thirty days of the completion of the 
inspection. 
[ 598 ] 
